Evidence map›Paper›PMID 34387631›Full record

ArticleJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2023

Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy-Response to Dr. Finsterer's Letter.

Claudia B Catarino, Bettina von Livonius, Claudia Priglinger, Klara Landau, Nancy J Newman, Marcela Votruba, Günther Rudolph, Thomas Klopstock

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 4 countries.

Claudia B CatarinoDepartment of Neurology (CBC, TK), Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) (TK), Munich, Germany; Department of Ophthalmology (BL, CP, GR), University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Department of Ophthalmology (KL), University Hospital and University of Zurich, Zurich, Switzerland; Emory University School of Medicine (NJN), Atlanta, Georgia; and School of Optometry and Vision Sciences (MV), Cardiff University, Cardiff, United Kingdom.
Bettina von Livonius
Claudia Priglinger
Klara Landau
Nancy J Newman
Marcela Votruba
Günther Rudolph
Thomas Klopstock
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Optic Atrophy, Hereditary, LeberAntioxidantsHumansUbiquinoneAntioxidantsidebenoneUbiquinone

Identifiers

PMID34387631
OpenAlexW3187158230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.